logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Thomas A Krenitsky

USPTO Granted Patents = 40 


Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 371(Granted Patents)


Company Filing History:

goldMedal27 out of 521 
 
Burroughs Wellcome Co.
 patents
silverMedal8 out of 281 
 
Glaxo Wellcome Inc.
 patents
bronzeMedal4 out of 5 
 
Krenitsky Pharmaceuticals, Inc.
 patents
4. 1 out of 1 
 
Remedi, Inc.
 patent

Years Active: 1978-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Monoamine Oxidase Inhibitors
Serotonin Receptor Agonists
Neurotrophic Activity
Pyrimidine Derivatives
Therapeutic Nucleosides
Antiviral Compounds
Guanine Esters
Deoxyribosides
Purine Derivatives
Acyclovir Production
Bacterial Phosphorylase
Tumor Treatment
40 patents (USPTO):Explore Patents
1. 12263155 - Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use (2025-04-01),
2. 7205297 - Substituted 5-alkynyl pyrimidines having neurotrophic activity (2007-04-17),
3. 6916820 - Neurotrophic substituted pyrimidines (2005-07-12),
4. 6583148 - Neurotrophic substituted pyrimidines (2003-06-24),
5. 6440965 - Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system (2002-08-27),
6. 5843917 - 5-Fluorouracil derivatives (1998-12-01),
7. 5821236 - Tumor treatment with arabinofuranosyl purine derivatives (1998-10-13),
8. 5747472 - Therapeutic methods for using ARA-G derivatives (1998-05-05),
9. 5663154 - 2',3'-dideoxy-3'-fluoro-purine ribonucleosides (1997-09-02),
10. 5637574 - Therapeutic nucleosides (1997-06-10),
11. 5574149 - Method of treating HIV infections with (1996-11-12),
12. 5559100 - Methods of treating hepatitis B virus infection with therapeutic (1996-09-24),
13. 5539098 - 5'-O-propionyl and 5'-O-butyryl esters of (1996-07-23),
14. 5492897 - Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside (1996-02-20),
15. 5424295 - 9-.beta.-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine (1995-06-13),

Title: **Innovative Contributions of Thomas A. Krenitsky**

Introduction

Thomas A. Krenitsky is an esteemed inventor based in Chapel Hill, NC, with an impressive portfolio of 39 patents to his name. His work focuses primarily on the development of pharmaceutical compositions aimed at treating various neurological disorders, showcasing his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest inventions are the **Substituted 5-alkynyl pyrimidines having neurotrophic activity**. This patent involves a series of novel substituted 5-alkynyl pyrimidines, including pharmaceutical compositions containing these compounds. The invention aims to provide therapeutic solutions for neurodegenerative conditions and neurological disorders affecting both the central and peripheral nervous systems. Specifically, these compounds are applicable in the treatment of age-related cognitive disorders, nerve injuries, and seizure disorders such as epilepsy.

Another noteworthy patent is the **Neurotrophic substituted pyrimidines**, which also pertains to a series of substituted pyrimidines and their use in pharmaceutical compositions. These compounds have therapeutic potential in addressing similar neurological conditions, marking them as significant contributions to the field of medicine.

Career Highlights

Thomas Krenitsky's career includes pivotal roles in influential companies like Burroughs Wellcome Co. and Glaxo Wellcome Inc., where he contributed to innovative research and development. His inventive spirit and expertise have positioned him as a significant figure in the pharmaceutical industry, particularly in the realm of neurology.

Collaborations

Throughout his career, Krenitsky has collaborated with notable individuals, including George Walter Koszalka and Janet L. Rideout. These partnerships have fostered a creative environment that has led to the development of impactful treatments for complex neurological disorders.

Conclusion

Thomas A. Krenitsky exemplifies the spirit of innovation and dedication to improving human health through his various patents and collaborations. His continued efforts in the field of neuropharmacology highlight the importance of research and development in creating solutions for pressing medical challenges. As he advances in his career, his contributions will undoubtedly continue to resonate in the realm of therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…